Convergent Genomics Home

Congress

Event Year

Reset

  • SUO I 2022

    Urine comprehensive genomic profiling of urothelial carcinoma patients undergoing intravesical therapy enables detection of actionable DNA mutations associated with drug response and risk stratification
    Abstract

  • ASCO GU I 2022

    Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction
    Abstract

  • CAP I 2022

    Urinary comprehensive genomic profiling: correlating urothelial carcinoma mutation with clinical risk and efficacy of intervention
    Abstract

  • AUA I 2022 

    Urine comprehensive genomic profiling predicts recurrence in patients with non-muscle invasive bladder cancer treated with intravesical therapy carcinoma
    Abstract

  • SUO I 2022 

    Urine comprehensive genomic profiling of urothelial carcinoma patients undergoing intravesical therapy enables detection of actionable DNA mutations associated with drug response and risk stratification
    Abstract

  • ASCO GU I 2022

    Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction
    Abstract

  • AUA 2022

    Urinary comprehensive genomic profiling predicts urothelial cancer up to 12 years ahead of clinical diagnosis: an expanded analysis of the Golestan Cohort Study.
    Abstract